Literature DB >> 24439875

ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.

Dan Hu1, Hector Barajas-Martínez2, Andre Terzic3, Sungjo Park3, Ryan Pfeiffer2, Elena Burashnikov2, Yuesheng Wu2, Martin Borggrefe4, Christian Veltmann4, Rainer Schimpf4, John J Cai5, Gi-Byong Nam6, Pramod Deshmukh7, Melvin Scheinman8, Mark Preminger9, Jonathan Steinberg10, Angélica López-Izquierdo11, Daniela Ponce-Balbuena11, Christian Wolpert4, Michel Haïssaguerre12, José Antonio Sánchez-Chapula11, Charles Antzelevitch13.   

Abstract

BACKGROUND: Genetic defects in KCNJ8, encoding the Kir6.1 subunit of the ATP-sensitive K(+) channel (I(K-ATP)), have previously been associated with early repolarization (ERS) and Brugada (BrS) syndromes. Here we test the hypothesis that genetic variants in ABCC9, encoding the ATP-binding cassette transporter of IK-ATP (SUR2A), are also associated with both BrS and ERS. METHODS AND
RESULTS: Direct sequencing of all ERS/BrS susceptibility genes was performed on 150 probands and family members. Whole-cell and inside-out patch-clamp methods were used to characterize mutant channels expressed in TSA201-cells. Eight ABCC9 mutations were uncovered in 11 male BrS probands. Four probands, diagnosed with ERS, carried a highly-conserved mutation, V734I-ABCC9. Functional expression of the V734I variant yielded a Mg-ATP IC₅₀ that was 5-fold that of wild-type (WT). An 18-y/o male with global ERS inherited an SCN5A-E1784K mutation from his mother, who displayed long QT intervals, and S1402C-ABCC9 mutation from his father, who displayed an ER pattern. ABCC9-S1402C likewise caused a gain of function of IK-ATP with a shift of ATP IC₅₀ from 8.5 ± 2 mM to 13.4 ± 5 μM (p<0.05). The SCN5A mutation reduced peak INa to 39% of WT (p<0.01), shifted steady-state inactivation by -18.0 mV (p<0.01) and increased late I(Na) from 0.14% to 2.01% of peak I(Na) (p<0.01).
CONCLUSION: Our study is the first to identify ABCC9 as a susceptibility gene for ERS and BrS. Our findings also suggest that a gain-of-function in I(K-ATP) when coupled with a loss-of-function in SCN5A may underlie type 3 ERS, which is associated with a severe arrhythmic phenotype.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ATP-sensitive potassium channel; J wave syndromes; Mutation; Sodium channel; Sudden cardiac death

Mesh:

Substances:

Year:  2014        PMID: 24439875      PMCID: PMC3947869          DOI: 10.1016/j.ijcard.2013.12.084

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  40 in total

1.  Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.

Authors:  Sungjo Park; Bernard B C Lim; Carmen Perez-Terzic; Georges Mer; Andre Terzic
Journal:  J Proteome Res       Date:  2008-03-01       Impact factor: 4.466

2.  Augmentation of J waves and electrical storms in patients with early repolarization.

Authors:  Gi-Byoung Nam; You-Ho Kim; Charles Antzelevitch
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

3.  A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction.

Authors:  Piercarlo Minoretti; Colomba Falcone; Alessia Aldeghi; Valentina Olivieri; Francesca Mori; Enzo Emanuele; Margherita Calcagnino; Diego Geroldi
Journal:  Clin Chim Acta       Date:  2006-03-06       Impact factor: 3.786

4.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.

Authors:  Naomasa Makita; Elijah Behr; Wataru Shimizu; Minoru Horie; Akihiko Sunami; Lia Crotti; Eric Schulze-Bahr; Shigetomo Fukuhara; Naoki Mochizuki; Takeru Makiyama; Hideki Itoh; Michael Christiansen; Pascal McKeown; Koji Miyamoto; Shiro Kamakura; Hiroyuki Tsutsui; Peter J Schwartz; Alfred L George; Dan M Roden
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance.

Authors:  Raphael Rosso; Evgeni Kogan; Bernard Belhassen; Uri Rozovski; Melvin M Scheinman; David Zeltser; Amir Halkin; Arie Steinvil; Karin Heller; Michael Glikson; Amos Katz; Sami Viskin
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

8.  Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel.

Authors:  Michel Haïssaguerre; Stéphanie Chatel; Frederic Sacher; Rukshen Weerasooriya; Vincent Probst; Gildas Loussouarn; Marc Horlitz; Ruedige Liersch; Eric Schulze-Bahr; Arthur Wilde; Stefan Kääb; Joseph Koster; Yoram Rudy; Hervé Le Marec; Jean Jacques Schott
Journal:  J Cardiovasc Electrophysiol       Date:  2009-01

9.  Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9.

Authors:  Keith J Smith; Andrew J Chadburn; Aiste Adomaviciene; Piercarlo Minoretti; Luigi Vignali; Enzo Emanuele; Paolo Tammaro
Journal:  Int J Cardiol       Date:  2013-06-03       Impact factor: 4.164

10.  Sudden cardiac arrest associated with early repolarization.

Authors:  Michel Haïssaguerre; Nicolas Derval; Frederic Sacher; Laurence Jesel; Isabel Deisenhofer; Luc de Roy; Jean-Luc Pasquié; Akihiko Nogami; Dominique Babuty; Sinikka Yli-Mayry; Christian De Chillou; Patrice Scanu; Philippe Mabo; Seiichiro Matsuo; Vincent Probst; Solena Le Scouarnec; Pascal Defaye; Juerg Schlaepfer; Thomas Rostock; Dominique Lacroix; Dominique Lamaison; Thomas Lavergne; Yoshifusa Aizawa; Anders Englund; Frederic Anselme; Mark O'Neill; Meleze Hocini; Kang Teng Lim; Sebastien Knecht; George D Veenhuyzen; Pierre Bordachar; Michel Chauvin; Pierre Jais; Gaelle Coureau; Genevieve Chene; George J Klein; Jacques Clémenty
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

View more
  48 in total

Review 1.  Genetics of Brugada syndrome.

Authors:  Hiroshi Watanabe; Tohru Minamino
Journal:  J Hum Genet       Date:  2015-07-30       Impact factor: 3.172

Review 2.  ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

Authors:  Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo
Journal:  Ageing Res Rev       Date:  2015-07-28       Impact factor: 10.895

Review 3.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 4.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

5.  Phosphorylation-dependent changes in nucleotide binding, conformation, and dynamics of the first nucleotide binding domain (NBD1) of the sulfonylurea receptor 2B (SUR2B).

Authors:  Elvin D de Araujo; Claudia P Alvarez; Jorge P López-Alonso; Clarissa R Sooklal; Marijana Stagljar; Voula Kanelis
Journal:  J Biol Chem       Date:  2015-07-21       Impact factor: 5.157

Review 6.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

7.  Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.

Authors:  Ehud Chorin; Dan Hu; Charles Antzelevitch; Aviram Hochstadt; Luiz Belardinelli; David Zeltser; Hector Barajas-Martinez; Uri Rozovski; Raphael Rosso; Arnon Adler; Jesaia Benhorin; Sami Viskin
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-10

Review 8.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

9.  Cantú Syndrome Associated with Ovarian Agenesis.

Authors:  Helena Fryssira; Stavroula Psoni; Styliani Amenta; Eirini Tsoutsou; Christalena Sofocleous; Emmanouil Manolakos; Maria Gavra; Hermann-Joseph Lüdecke; Johanna-Christina Czeschik
Journal:  Mol Syndromol       Date:  2017-05-10

10.  Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.

Authors:  Dan Hu; Hector Barajas-Martínez; Ryan Pfeiffer; Fabio Dezi; Jenna Pfeiffer; Tapan Buch; Matthew J Betzenhauser; Luiz Belardinelli; Kristopher M Kahlig; Sridharan Rajamani; Harry J DeAntonio; Robert J Myerburg; Hiroyuki Ito; Pramod Deshmukh; Mark Marieb; Gi-Byoung Nam; Atul Bhatia; Can Hasdemir; Michel Haïssaguerre; Christian Veltmann; Rainer Schimpf; Martin Borggrefe; Sami Viskin; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.